Search Results - "Kashtalap, V"

Refine Results
  1. 1

    Lipitension – myth or reality? Opinion of a practicing cardiologist (letter to the editor) by Kashtalap, V. V.

    “…   The article (letter to the editor) presents current data on the prevalence of arterial hypertension and dyslipidemia according to domestic and foreign…”
    Get full text
    Journal Article
  2. 2

    Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation) by Kashtalap, V. V.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (08-12-2022)
    “…The article presents epidemiological data on the high prevalence of hypertension and dyslipidemia comorbidity in the general population, as well as shows the…”
    Get full text
    Journal Article
  3. 3

    Single-pill combination of indapamide and perindopril: potential of practical application by Kochergina, A. M., Kashtalap, V. V.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (17-04-2024)
    “…The effectiveness of blood pressure control can be increased with the use of single-pill combinations. When choosing an agent, the evidence of its components…”
    Get full text
    Journal Article
  4. 4

    Endothelial protective effect of pitavastatin by Berns, A. S., Kashtalap, V. V.

    “…The article discusses topical issues of modern concepts of aging, including vascular aging due to the progression of endothelial dysfunction, atherogenesis,…”
    Get full text
    Journal Article
  5. 5

    Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? by D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash

    “…Aim. To compare the clinical effectiveness of two patient management programs for 12 months after myocardial infarction (MI) (standard outpatient monitoring…”
    Get full text
    Journal Article
  6. 6

    Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? by Barbarash, O L, Kashtalap, V V

    Published in Terapevtic̆eskii arhiv (15-12-2019)
    “…In the review article are provided the approaches to the therapy for improvement of prognosis in patients with peripheral and multifocal atherosclerosis which…”
    Get full text
    Journal Article
  7. 7

    Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban by Barbarash, O. L., Kashtalap, V. V.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (18-11-2020)
    “…The review article presents current data on the clinical and prognostic significance, as well as on the prevalence of comorbidities in patients with atrial…”
    Get full text
    Journal Article
  8. 8

    The role of psycho-emotional factors in assessing the prognosis of different types of myocardial infarction by Kinash, V. I., Kashtalap, V. V., Vorobiev, A. S., Urvantseva, I. A., Kovalenko, L. V.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (01-03-2024)
    “…Aim.  To study the features of psycho-emotional status and its clinical and prognostic significance in patients with type 1 and 2 myocardial infarction (MI)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus by Barbarash, O. L., Kashtalap, V. V.

    Published in Aterotromboz (Online) (02-06-2020)
    “…The review article presents current positions about prevalence of multifocal atherosclerosis and type 2 diabetes mellitus in patients with coronary artery…”
    Get full text
    Journal Article
  11. 11

    Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors by Sedykh, D. Yu, Kashtalap, V. V., Khryachkova, O. N., Petrova, T. S., Barbarash, O. L.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (01-07-2022)
    “…Aim . To assess the efficacy and safety of 6-month combined lipid-lowering therapy with a PCSK9 inhibitor in patients with very high cardiovascular risk (CVR)…”
    Get full text
    Journal Article
  12. 12

    Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? by Barbarash, O. L., Kashtalap, V. V., Shibanova, I. A.

    “…Modern data on comorbidity in coronary artery disease (CAD) are presented in the article, as well as its frequency, dependence on the age, clinical and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel by Kashtalap, V. V., Barbarash, O. L.

    Published in Medicinskij sovet (09-10-2019)
    “…In the review based on existing clinical recommendations and guidelines of the European cardiology society and results of clinical and register trials…”
    Get full text
    Journal Article
  15. 15

    Socio-economic and behavioral «portrait» of patients with myocardial infarction by Barbarash, O. L., Sedykh, D. Yu, Petrova, T. S., Hryachkova, O. N., Kashtalap, V. V., Artamonova, G. V.

    Published in Ateroskleroz (20-07-2022)
    “…Aim. To identify the specifics of socioeconomic status and behavioral patterns in patients with myocardial infarction (MI) compared with the data of regional…”
    Get full text
    Journal Article
  16. 16

    Healthy nutrition in secondary prevention after myocardial infarction. What to focus on? by Barbarash, O. L., Sedykh, D. Yu, Petrova, T. S., Kashtalap, V. V., Tsygankova, D. P.

    “…Rationalization of dietary behavior in patients after myocardial infarction is the subject of numerous discussions. Despite the proven preventive effect of a…”
    Get full text
    Journal Article
  17. 17

    Clopidogrel as a part of double disaggregant therapy in ACS: a reasonable choice in complex clinical situations by Kashtalap, V. V., Barbarash, O. L.

    Published in Medicinskij sovet (04-04-2019)
    “…Based on the recommendations of the European Heart Society and the results of clinical and register studies, the article highlights the complex issues that…”
    Get full text
    Journal Article
  18. 18

    Combined use of the GRACE ACS risk score and comorbidity indices to increase the effectiveness of hospital mortality risk assessment in patients with acute coronary syndrome by Zykov, Mikhail V., Dyachenko, Nikita V., Velieva, Rufana M., Kashtalap, Vasily V., Barbarash, Olga L.

    Published in Terapevtic̆eskii arhiv (12-08-2022)
    “…Aim. To assess the possibilities of using comorbidity indices together with the GRACE (Global Registry of Acute Coronary Events) scale to assess the risk of…”
    Get full text
    Journal Article
  19. 19

    Regional differences in cardiac mortality rates in Russia: the role of statistical features by Drapkina, O. M., Samorodskaya, I. V., Yavelov, I. S., Kashtalap, V. V., Barbarash, O. I.

    “…Aim . To analyze the contribution of cardiac causes to all-cause mortality, to characterize the differences in standardized mortality rates (SMRs) in Russian…”
    Get full text
    Journal Article
  20. 20

    Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice by Barbarash, O. L., Kashtalap, V. V.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (25-11-2018)
    “…The review article presents the state-of-the-art of use of dual antiplatelet therapy (DAPT) in patients with acute coronary syndrome (ACS) based on modern…”
    Get full text
    Journal Article